Our sister site, Drug Delivery Business News, reports today that the company opened its plant in Kilkenny in the South-East region of Ireland. The site serves as a global manufacturing center of excellence for Abbott’s Diabetes Care business.
Spanning 30,000 square meters, the Kilkenny facility produces FreeStyle Libre 3 sensors to support Abbott’s continuous glucose monitoring (CGM) portfolio. Powered by six air-to-water heat pumps, the fully electric site features nearly 600 solar panels on the roof. It also has tanks for collecting rainwater to use onsite.
(Read more about the medtech industry’s investment in Ireland over the years HERE.)
Outside Ireland, Abbott also plans to expand manufacturing capacity across Europe with a further £85 million investment in its Witney facility in Oxfordshire, UK.
Get the full story at our sister site, Drug Delivery Business News.
